NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

ex, curious how you stick to your guns that the trial failed (your reiteration of “but placebo vs ITT!”) when Dr Linda Liau’s SNO presentation is titled:

The same way I consider CVM's trial to have failed when they PR'd the abstract::

Leukocyte interleukin injection (LI) immunotherapy extends overall survival (OS) in treatment-naive low-risk (LR) locally advanced primary squamous cell carcinoma of the head and neck: The IT-MATTERS study.

Randomized trials fail to show OS improvement between arms. One falls back to a subset, the other falls back to poorly matched ECA.